Coronavirus
COVID-19: Pfizer/BioNTech vaccine gets Saudi Arabia approval
The COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and German partner BioNTech has been approved for use in Saudi Arabia on Thursday.
Saudi Arabia’s state news agency SPA reported that the Saudi Food and Drug Authority made the approval in response to a request from Pfizer, clearing the way for health agencies in the kingdom to import and use the vaccine.
The agency added that the approval for the vaccine’s registration and use was based on safety and effectiveness data that Pfizer had provided.
No specific dates have been given for the arrival of the vaccine and the start of its use in the country.
Saudi health authorities in November said the COVID-19 vaccines would be made available to citizens and foreign residents for free.
Earlier, Bahrain, another Gulf country, announced it had approved the emergency use of Pfizer/BioNTech vaccine.
The approval made Bahrain the second country in the world to grant an emergency use authorisation for the vaccine after Britain. (dpa/NAN)
-
News12 hours ago
Ogun schools resume third academic term today
-
News7 hours ago
Court slams Linda Ikeji N30m damages over libelous post against NBM
-
News12 hours ago
Five dead as deadly tornadoes hits US states
-
Economy12 hours ago
Don’t give tax holidays based on patronage, CITN tells FG
-
Crime10 hours ago
NDLEA busts man carrying 4,000 tramadol pills at Lagos airport
-
Politics10 hours ago
Imo ex-gov Ihedioha pays visit to Otti
-
News9 hours ago
NFL star Tank Dell injured in Florida shooting
-
Metro10 hours ago
Lagos govt cracks down on illegal structures to curb flooding